KR930002729B1 - 트리아졸 항진균제 - Google Patents

트리아졸 항진균제 Download PDF

Info

Publication number
KR930002729B1
KR930002729B1 KR1019890011503A KR890011503A KR930002729B1 KR 930002729 B1 KR930002729 B1 KR 930002729B1 KR 1019890011503 A KR1019890011503 A KR 1019890011503A KR 890011503 A KR890011503 A KR 890011503A KR 930002729 B1 KR930002729 B1 KR 930002729B1
Authority
KR
South Korea
Prior art keywords
compound
formula
difluorophenyl
solution
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019890011503A
Other languages
English (en)
Korean (ko)
Other versions
KR900003157A (ko
Inventor
피터 디킨슨 로저
리챠드슨 케네스
Original Assignee
화이자 인코퍼레이티드
데이비드 존 우드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10642109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR930002729(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 화이자 인코퍼레이티드, 데이비드 존 우드 filed Critical 화이자 인코퍼레이티드
Publication of KR900003157A publication Critical patent/KR900003157A/ko
Application granted granted Critical
Publication of KR930002729B1 publication Critical patent/KR930002729B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019890011503A 1988-08-13 1989-08-12 트리아졸 항진균제 Expired - Lifetime KR930002729B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819308A GB8819308D0 (en) 1988-08-13 1988-08-13 Triazole antifungal agents
GB8819308.1 1988-08-13

Publications (2)

Publication Number Publication Date
KR900003157A KR900003157A (ko) 1990-03-23
KR930002729B1 true KR930002729B1 (ko) 1993-04-09

Family

ID=10642109

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890011503A Expired - Lifetime KR930002729B1 (ko) 1988-08-13 1989-08-12 트리아졸 항진균제

Country Status (39)

Country Link
US (2) US5116844A (https=)
EP (1) EP0357241B1 (https=)
JP (2) JPH0786100B2 (https=)
KR (1) KR930002729B1 (https=)
CN (1) CN1029231C (https=)
AP (1) AP104A (https=)
AR (1) AR246963A1 (https=)
AU (1) AU602638B2 (https=)
BG (1) BG60865B1 (https=)
CA (1) CA1341325C (https=)
CY (1) CY1968A (https=)
CZ (1) CZ284318B6 (https=)
DD (1) DD284010A5 (https=)
DE (1) DE68913105T2 (https=)
DK (1) DK172471B1 (https=)
ES (1) ES2062009T4 (https=)
FI (1) FI96859C (https=)
GB (1) GB8819308D0 (https=)
HK (1) HK1000320A1 (https=)
HU (2) HU205348B (https=)
IE (1) IE61412B1 (https=)
IL (1) IL91231A (https=)
IN (1) IN175438B (https=)
IS (1) IS1586B (https=)
LV (1) LV10714B (https=)
MA (1) MA21610A1 (https=)
MX (1) MX17169A (https=)
MY (1) MY105092A (https=)
NO (1) NO174101C (https=)
NZ (1) NZ230283A (https=)
OA (1) OA09126A (https=)
PE (1) PE1591A1 (https=)
PL (2) PL162953B1 (https=)
PT (1) PT91440B (https=)
RO (1) RO108453B1 (https=)
RU (2) RU1836366C (https=)
SK (1) SK476189A3 (https=)
YU (1) YU47093B (https=)
ZA (1) ZA896151B (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620342B2 (en) * 1987-09-24 1992-02-20 Philip Morris Products Inc. Smoking compositions containing a heteroaromatic flavorant-release additive
DK105189A (da) * 1988-03-04 1989-09-05 Sankyo Co Triazolderivater og fremgangsmaade til fremstilling deraf samt fungicide midler indeholdende derivaterne
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
US5493024A (en) * 1991-04-11 1996-02-20 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
GB9317491D0 (en) * 1993-08-23 1993-10-06 Fujisawa Pharmaceutical Co New compound and a process for preparation thereof
SE508401C2 (sv) * 1993-06-09 1998-10-05 Sca Hygiene Prod Ab Absorberande struktur och absorberande alster, som innefattar strukturen ifråga
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
CA2180091A1 (en) * 1995-07-08 1997-01-09 Hiroki Kodama Optically active triazole derivative, process for producing the same, antifungal agent, and method for using the same
ES2107376B1 (es) * 1995-08-02 1998-07-01 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
BR9606547A (pt) * 1995-08-02 1997-10-14 Uriach & Cia Sa J Novos derivados de pirimidona com atividade fungicida
BR9606546A (pt) * 1995-08-02 1998-07-14 Uriach & Cia Sa J Novas carboxamidas com atividade fungicida
GB9516121D0 (en) 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
GB9605705D0 (en) * 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
US6699853B2 (en) 1997-06-16 2004-03-02 Hoechst Schering Agrevo Gmbh 4-haloalkyl-3-heterocyclylpyridines, 4-haloalkyl-5-heterocyclyl-pyrimidines and 4-trifluoromethyl-3-oxadiazolylpyridines, processes for their preparation, compositions comprising them, and their use as pesticides
DE19725450A1 (de) 1997-06-16 1998-12-17 Hoechst Schering Agrevo Gmbh 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9713149D0 (en) * 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
ES2159488B1 (es) 2000-03-07 2002-04-16 Uriach & Cia Sa J Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
FR2814073B1 (fr) * 2000-09-21 2005-06-24 Yang Ji Chemical Company Ltd Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
RU2256655C1 (ru) * 2004-01-27 2005-07-20 Закрытое акционерное общество Фирма "Август" Способ получения 1-(4-хлорфенил)-3-(1,2,4-триазол-1-ил-метил)-4,4-диметилпентан-3-ола
RU2295958C1 (ru) * 2005-07-04 2007-03-27 Федеральное государственное унитарное предприятие "Центр по химии лекарственных средств" (ФГУП ЦХЛС-ВНИХФИ) Фармацевтический состав для лечения грибковых заболеваний и способ его получения
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
WO2008021049A2 (en) 2006-08-07 2008-02-21 Stiefel Laboratories, Inc. Crystalline antifungal compounds
US20110224232A1 (en) * 2008-05-06 2011-09-15 Board Of Regents, The University Of Texas System Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation
BR112012000170A2 (pt) * 2009-07-08 2019-09-24 Bayer Cropscience Ag derivados de fenil (oxi/tio) alcanol substituídos
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
WO2011110198A1 (en) 2010-03-10 2011-09-15 Synthron B.V. A process for making voriconazole
AU2011242562B2 (en) * 2010-04-24 2016-10-13 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
US9056855B2 (en) 2010-10-28 2015-06-16 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
RU2478106C2 (ru) * 2010-11-25 2013-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) СОЕДИНЕНИЯ НА ОСНОВЕ КОМПЛЕКСОВ ГИПЕРРАЗВЕТВЛЕННЫХ ПОЛИМЕРОВ Boltorn H, ОБЛАДАЮЩИЕ АНТИКАНДИДОЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
WO2012114273A1 (en) 2011-02-21 2012-08-30 Ranbaxy Laboratories Limited An improved process for the preparation of voriconazole and intermediates thereof
PL2720723T3 (pl) 2011-06-15 2018-10-31 Synthon Bv Stabilizowana kompozycja worykonazolu
AU2012273100B2 (en) * 2011-06-19 2017-05-25 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
KR20140040235A (ko) * 2011-06-19 2014-04-02 비아멧 파마슈티컬즈, 인코포레이티드 금속효소 억제제 화합물
US8940735B2 (en) * 2011-06-23 2015-01-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
TWI658039B (zh) * 2011-07-08 2019-05-01 維愛美製藥公司 金屬酶抑制劑化合物
TWI646088B (zh) * 2012-03-16 2019-01-01 維愛美製藥公司 金屬酶抑制劑化合物
CA2872958A1 (en) 2012-05-11 2013-11-14 Cipla Limited Pharmaceutical composition
CN102796087B (zh) * 2012-09-04 2015-04-15 西南大学 香豆素三唑醇及其制备方法和用途
US20150246898A1 (en) * 2012-09-12 2015-09-03 Dow Agrosciences Llc Metalloenzyme inhibitor compounds
IN2015DN02877A (https=) * 2012-10-15 2015-09-11 Pfizer Ireland Pharmaceuticals
US9447073B2 (en) 2013-05-28 2016-09-20 Viamet Pharmaceuticals, Inc. Fungicidal compositions
RU2563811C1 (ru) * 2014-08-08 2015-09-20 Федеральное государственное бюджетное учреждение науки Институт химической физики им. Н.Н. Семенова Российской академии наук (ИХФ РАН) Фармацевтическая композиция для лечения грибковых заболеваний
EP3201188A1 (en) 2014-10-02 2017-08-09 Bayer CropScience Aktiengesellschaft Novel triazole derivatives useful as fungicides
CR20170574A (es) 2015-05-18 2018-07-19 Viamet Pharmaceuticals Inc Compuestos antifíngicos
BR112020025987A2 (pt) 2018-06-21 2021-03-23 Yumanity Therapeutics, Inc. composições e métodos para tratamento e prevenção de distúrbios neurológicos
CN115650925B (zh) * 2022-09-07 2024-09-24 中国人民解放军海军军医大学 一种三氮唑醇类衍生物及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158741A3 (en) * 1980-11-19 1986-02-12 Imperial Chemical Industries Plc Intermediates for fungicidal triazole and imidazole compounds
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
DE3228870A1 (de) * 1982-08-03 1984-02-09 Bayer Ag, 5090 Leverkusen Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE3242252A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen Heterocyclisch substituierte hydroxyalkyl-azolyl-derivate
DE3242236A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen "antimykotische mittel"
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
DE3307218A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte diazolylalkyl-carbinole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
GB8307232D0 (en) * 1983-03-16 1983-04-20 Pfizer Ltd Antifungal agents
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
GB8313235D0 (en) * 1983-05-13 1983-06-22 Pfizer Ltd Antifungal agents
DE3325313A1 (de) * 1983-07-13 1985-01-31 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
DE3440117A1 (de) * 1984-11-02 1986-05-15 Bayer Ag, 5090 Leverkusen Substituierte azolylcyclopropyl-azolylmethyl-carbinol-derivate
GB8506619D0 (en) * 1985-03-14 1985-04-17 Pfizer Ltd Triazole antifungal agents
ZA874485B (en) * 1986-06-23 1989-02-22 Du Pont Antifungal carbinols
DE3813841A1 (de) * 1987-06-03 1988-12-15 Bayer Ag Heterocyclische hydroxyethylazole
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
DK105189A (da) * 1988-03-04 1989-09-05 Sankyo Co Triazolderivater og fremgangsmaade til fremstilling deraf samt fungicide midler indeholdende derivaterne

Also Published As

Publication number Publication date
RU1836366C (ru) 1993-08-23
NZ230283A (en) 1991-02-26
ZA896151B (en) 1991-03-27
MY105092A (en) 1994-08-30
IL91231A0 (en) 1990-03-19
MA21610A1 (fr) 1990-04-01
DE68913105D1 (de) 1994-03-24
AU602638B2 (en) 1990-10-18
SK280775B6 (sk) 2000-07-11
AR246963A1 (es) 1994-10-31
HU205348B (en) 1992-04-28
KR900003157A (ko) 1990-03-23
PL163756B1 (pl) 1994-04-29
ES2062009T3 (es) 1994-12-16
IE892582L (en) 1990-02-13
DD284010A5 (de) 1990-10-31
JPH0786100B2 (ja) 1995-09-20
BG89519A (bg) 1993-12-24
DE68913105T2 (de) 1994-05-26
FI893809L (fi) 1990-02-14
IL91231A (en) 1994-08-26
RO108453B1 (ro) 1994-05-31
CN1029231C (zh) 1995-07-05
DK172471B1 (da) 1998-09-07
HU211511A9 (en) 1995-11-28
IS3499A7 (is) 1990-02-14
FI96859C (fi) 1996-09-10
HUT52089A (en) 1990-06-28
PT91440B (pt) 1995-05-04
BG60865B1 (bg) 1996-05-31
EP0357241B1 (en) 1994-02-16
IN175438B (https=) 1995-06-17
ES2062009T4 (es) 2006-07-01
YU158789A (en) 1991-04-30
FI893809A0 (fi) 1989-08-11
CY1968A (en) 1997-09-05
JPH07173154A (ja) 1995-07-11
DK394589D0 (da) 1989-08-11
YU47093B (sh) 1994-12-28
US5116844A (en) 1992-05-26
HK1000320A1 (en) 1998-02-27
MX17169A (es) 1993-08-01
LV10714B (en) 1995-12-20
OA09126A (fr) 1991-10-31
CZ284318B6 (cs) 1998-10-14
PL162953B1 (pl) 1994-01-31
NO174101B (no) 1993-12-06
CN1040795A (zh) 1990-03-28
IS1586B (is) 1996-03-01
AU3893089A (en) 1990-03-22
CA1341325C (en) 2001-12-11
GB8819308D0 (en) 1988-09-14
LV10714A (lv) 1995-06-20
EP0357241A1 (en) 1990-03-07
SK476189A3 (en) 2000-07-11
PT91440A (pt) 1990-03-08
AP104A (en) 1990-11-02
JPH02104583A (ja) 1990-04-17
NO893248L (no) 1990-02-14
PE1591A1 (es) 1991-03-16
FI96859B (fi) 1996-05-31
CZ476189A3 (cs) 1998-09-16
AP8900135A0 (en) 1989-10-31
US5364938A (en) 1994-11-15
NO174101C (no) 1994-03-16
NO893248D0 (no) 1989-08-11
RU2095358C1 (ru) 1997-11-10
IE61412B1 (en) 1994-11-02
DK394589A (da) 1990-02-14
JP2713394B2 (ja) 1998-02-16

Similar Documents

Publication Publication Date Title
KR930002729B1 (ko) 트리아졸 항진균제
HK1000320B (en) Triazole antifungal agents
JP2997947B2 (ja) トリアゾール化合物およびその用途
SK278215B6 (en) Triazole derivatives, method of preparation thereof, intermediate products of these methods, pharmaceutical and antifungal agent and application of these compounds
US5541203A (en) Triazole antifungal agents
CZ415597A3 (cs) Triazolové sloučeniny, způsoby a meziprodukty pro jejich výrobu a farmaceutické prostředky na jejich bázi a jejich použití
JPS6411631B2 (https=)
JPS6346072B2 (https=)
US5206364A (en) Triazole antifungal agents
JPH08325243A (ja) 新規なトリアゾール誘導体、その製造方法及びこれを有効成分とする抗真菌剤
IL106262A (en) Intermediates to triazole antifungal agents
KR0142354B1 (ko) 트리아졸 화합물의 중간체의 제조방법
JPH05194429A (ja) アゾール化合物、その製造法および用途
JPH04208269A (ja) 新規なトリアゾール誘導体およびその塩
JPWO1995026343A1 (ja) 新規なトリアゾール誘導体及びこれを有効成分とする抗真菌剤

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890812

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19890812

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19911005

Patent event code: PE09021S01D

E801 Decision on dismissal of amendment
PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 19920325

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 19920107

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19930227

Appeal identifier: 1992202001276

Request date: 19920627

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19930312

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19930623

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19930707

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19930707

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19960404

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19970404

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19980320

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19990304

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20000210

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20010307

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20020326

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20030331

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20040331

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20050331

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20060331

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20070330

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20080331

Start annual number: 16

End annual number: 16

FPAY Annual fee payment

Payment date: 20090331

Year of fee payment: 17

PR1001 Payment of annual fee

Payment date: 20090331

Start annual number: 17

End annual number: 17

EXPY Expiration of term
PC1801 Expiration of term